Table of Contents

company-logo

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma. It also develops CAN-3110, which is in Phase I clinical trials for the treatment of recurrent glioblastoma. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. The company was incorporated in 2003 and is based in Needham, Massachusetts.

Candel Therapeutics Dividend Announcement

• Candel Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Candel Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Candel Therapeutics Dividend History

Candel Therapeutics Dividend Yield

Candel Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Candel Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Candel Therapeutics Financial Ratios

P/E ratio-2.78
PEG ratio0.06
P/B ratio-13.93
ROE-629.29%
Payout ratio0.00%
Current ratio1.62
Quick ratio1.62
Cash Ratio1.53

Candel Therapeutics Dividend FAQ

Does Candel Therapeutics stock pay dividends?
Candel Therapeutics does not currently pay dividends to its shareholders.
Has Candel Therapeutics ever paid a dividend?
No, Candel Therapeutics has no a history of paying dividends to its shareholders. Candel Therapeutics is not known for its dividend payments.
Why doesn't Candel Therapeutics pay dividends?
There are several potential reasons why Candel Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Candel Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Candel Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Candel Therapeutics a dividend aristocrat?
Candel Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Candel Therapeutics a dividend king?
Candel Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Candel Therapeutics a dividend stock?
No, Candel Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Candel Therapeutics stocks?
To buy Candel Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Candel Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.